In 2025, the FDA issued more than 50 warning letters to compounders and telehealth companies for falsely marketing their GLP-1 medications as equivalent to their FDA-approved counterparts
A: While semaglutide is not directly harmful to the kidneys, it may affect kidney function in some people, especially those who already have kidney disease
In conclusion, the landscape of diabetes and weight management is evolving, with Semaglutide based medications like Ozempic and Wegovy, along with the introduction of Mounjaro, offering innovative paths toward managing these complex conditions
Zepbound 2.5mg is the most frequently reported dose of the drug
The result is lower appetite, smaller portions, and steady weight loss over months